FDA Inspection
DeVere Company, Inc.DeVere Company, Inc. – FDA Inspection, Jun 4, 2025
Record Details
This FDA Inspection record concerns DeVere Company, Inc., with an inspection on June 4, 2025, issued by the Minneapolis District Office, covering human drugs.
View Company Profile
ID · 820b2885-a281-4da2-a581-96763d20f2c1
Inspection Facts
- Inspection number
- 1272054
- FDA center
- Human Drugs
FDA Citations
9- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.165(e)Test methods
- 21 CFR 211.166(a)Written program not followed
- 21 CFR 211.188(b)Batch production and Batch Control Record Requirements
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.84(d)(2)Component identification test
- 21 CFR 211.84(d)(2)Establish reliability of supplier's C of A
Full citation text and observation details available on the Dashboard.
Other FDA inspections of DeVere Company, Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| February 2, 2018 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
Other documents for DeVere Company, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.